Prodia Diagnostic Line Tbk vs Chandra Asri Pacific Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume), while Chandra Asri Pacific Tbk. trades at Rp2,060 (market cap 186.86T, 330.51M 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 397.1× Prodia Diagnostic Line Tbk's market cap, and Chandra Asri Pacific Tbk. is more actively traded (330.51M versus 28.43M). Which is the better fit depends on your goals.
| PRDL | TPIA | |
|---|---|---|
Market Cap | 470.58B | 186.86T |
Volume | 28.43M | 330.51M |
Lot | 284.34K | 3.31M |
Turnover | 7.8B | 687.87B |
Average Price | 274.19 | 2,081.25 |
Value | 7.8B | 687.87B |
Indicative Equilibrium Price | 270 | 2,060 |
Indicative Equilibrium Volume | 2.1K | 66.16K |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Read more on TPIA →